ASX:OBJ

Wellfully Limited (OBJ.AX) Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive OBJ News and Ratings via Email

Sign-up to receive the latest news and ratings for Wellfully Limited (OBJ.AX) and its competitors with MarketBeat's FREE daily newsletter.

About Wellfully Limited (OBJ.AX)

OBJ Limited develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Australia. The company provides partnering services and product solutions for technologies in transdermal and intra-dermal drug delivery; therapeutic and dermatological skincare; cosmetic and non-medicinal active ingredient; oral health; haircare solutions utilizing enhanced brushes and applicators; high penetration surface hygiene technologies; fabric and carpet cleaning technologies; and industrial surface interface systems. It offers various technology platforms, such as Static Micro-arrays, a film based micro-array technology for patches, masks, dressings, and other topical applications; and Field in Motion Micro-arrays, a magnetic micro-array film for use in brushes, applicators, and wipes; Dermaportation, a product development platform for a range of commercial applications; eSkin, a multi-product delivery system that offers a range of product-specific, time-varying magnetic fields for enhanced delivery of multiple formulations; and measured dose delivery devices and packaging solutions. OBJ Limited was founded in 2004 and is based in Leederville, Australia.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Diagnostics & Research
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:OBJ
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.obj.com.au
Phone: 61 8 9443 3011
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: $1.48 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A($0.01) per share
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.43
Quick Ratio: 0.43

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Wellfully Limited (OBJ.AX).

0.0 Community Rank

Outperform Votes
Wellfully Limited (OBJ.AX) has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Wellfully Limited (OBJ.AX) has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Wellfully Limited (OBJ.AX) and other stocks. Vote “Outperform” if you believe OBJ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OBJ will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Wellfully Limited (OBJ.AX) does not currently pay a dividend.
Dividend Growth
Wellfully Limited (OBJ.AX) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Wellfully Limited (OBJ.AX) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Wellfully Limited (OBJ.AX) (ASX:OBJ) Frequently Asked Questions

What stocks does MarketBeat like better than Wellfully Limited (OBJ.AX)?: Wall Street analysts have given Wellfully Limited (OBJ.AX) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Wellfully Limited (OBJ.AX) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are Wellfully Limited (OBJ.AX)'s key executives?: Wellfully Limited (OBJ.AX)'s management team includes the following people:
Mr. Jeffrey David Edwards, Founder, MD, Technical Director & Exec. Director
Mr. Paul Peros, Chief Exec. Officer
Dr. Matthew McIldowie, Chief Scientific Officer
Mr. John Joseph Palermo B.Bus, CA, FCA, ASCA, J.P., ACIS, AGIA, Snr, Company Sec.
Dr. Michael Roberts, Scientific Adviser
Who are some of Wellfully Limited (OBJ.AX)'s key competitors?: Some companies that are related to Wellfully Limited (OBJ.AX) include Australian Clinical Labs (ACL), BARD1 Life Sciences (BD1), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), Cryosite (CTE), dorsaVi (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures (GSS), Genetic Technologies (GTG), Imagin Medical (IME), Imagion Biosystems (IBX), Integral Diagnostics (IDX), Lifespot Health (LSH) and Med BioGene (MBGNF).
View all of OBJ's competitors.
What is Wellfully Limited (OBJ.AX)'s stock symbol?: Wellfully Limited (OBJ.AX) trades on the ASX under the ticker symbol "OBJ."
How much money does Wellfully Limited (OBJ.AX) make?: Wellfully Limited (OBJ.AX) has a market capitalization of $0.00 and generates $1.48 million in revenue each year.
What is Wellfully Limited (OBJ.AX)'s official website?: The official website for Wellfully Limited (OBJ.AX) is www.obj.com.au.
How can I contact Wellfully Limited (OBJ.AX)?: The company can be reached via phone at 61 8 9443 3011.

This page was last updated on 10/25/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.